Apogee Therapeutics, Inc. Quarterly Liabilities, Current in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Apogee Therapeutics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2022 to Q2 2024.
Apogee Therapeutics, Inc. Liabilities, Current for the quarter ending June 30, 2024 was $24.6M, a 39.8% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$24.6M	+$7M	+39.8%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$21.6M			Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$20.6M	+$10.6M	+106%	Dec 31, 2023	10-Q	2024-08-12
Q3 2023	$17.2M			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$17.6M			Jun 30, 2023	10-Q	2023-08-28
Q4 2022	$9.98M			Dec 31, 2022	10-K	2024-03-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.